World Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,975
Closed -$235K 885
2020
Q4
$235K Buy
+1,975
New +$213K 0.02% 749
2020
Q2
Sell
-2,045
Closed -$204K 823
2020
Q1
$204K Sell
2,045
-59
-3% -$6.4K 0.02% 761
2019
Q4
$242K Sell
2,104
-275
-12% -$33.3K 0.01% 895
2019
Q3
$300K Sell
2,379
-12
-0.5% -$1.52K 0.01% 832
2019
Q2
$288K Sell
2,391
-23
-1% -$2.26K 0.01% 865
2019
Q1
$211K Sell
2,414
-4
-0.2% -$364 0.01% 1022
2018
Q4
$242K Sell
2,418
-197
-8% -$20.7K 0.01% 860
2018
Q3
$300K Sell
2,615
-11
-0.4% -$1.14K 0.01% 938
2018
Q2
$235K Sell
2,626
-112
-4% -$9.46K 0.01% 1086
2018
Q1
$200K Buy
+2,738
New +$188K 0.01% 1226
2013
Q4
Sell
-5,771
Closed -$230K 1602
2013
Q3
$230K Sell
5,771
-1,012
-15% -$42.5K 0.01% 1447
2013
Q2
$280K Buy
+6,783
New +$275K 0.01% 1365

Other funds holding HAE

World Asset Management's HAE Position: Q1 2021 in Review

World Asset Management sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 1,975 shares — an estimated $235K sold.

World Asset Management first reported a position in HAE in Q2 2013 and held it in 12 quarters. The position peaked at $300K in Q3 2019. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

  • World Asset Management reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
  • World Asset Management sold 1,975 Haemonetics shares in Q1 2021, an estimated $235K.
  • World Asset Management first reported a position in Haemonetics in Q2 2013 and held it in 12 quarters.
  • World Asset Management's Haemonetics position peaked at $300K in Q3 2019.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on World Asset Management's 13F filing for Q1 2021, filed 10 May 2021.